Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients
Randomized, Controlled Trial of an Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients
1 other identifier
interventional
251
1 country
1
Brief Summary
To test the effect of an individualized exercise oncology program on healthcare utilization, 30-day hospital readmission, pain, and cancer treatment tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 23, 2019
CompletedFirst Submitted
Initial submission to the registry
September 25, 2019
CompletedFirst Posted
Study publicly available on registry
September 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2021
CompletedResults Posted
Study results publicly available
June 7, 2024
CompletedJune 7, 2024
June 1, 2024
2.2 years
September 25, 2019
April 5, 2022
June 5, 2024
Conditions
Outcome Measures
Primary Outcomes (12)
Missed Fractions
Total number of missed fractions, determined by electronic medical record
12 weeks
Numbers of Breaks in Cancer Treatment
Defined as missing 3 or more fractions due to patient condition, determined by electronic medical record
12 weeks
Cost of Emergency Room Visits
Medical expenditure and utilization, for each time a patient utilized an emergency room visit for the purpose of managing health problems in addition to the planned cancer care, determined by electronic medical record.
12 weeks
Encounters
Number of inpatient and outpatient hospital encounters, determined by electronic medical record
12 weeks
Cost of Total Unplanned Expenditures
Number of hospital readmissions for the same presenting issue, determined by electronic medical record
12 weeks
Cost of Hospital Inpatient Care
Hospital length of stay, in days, if applicable. Determined by electronic medical record.
12 weeks
Cancer Treatment Adherence
Percentage of patient adherence to their cancer treatment, determined by electronic medical record
12 weeks
Cancer Treatment Symptom Management Medications
Number of the different types of medications taken by patients for symptom management during their cancer treatment. Determined by electronic medical record.
12 weeks
Cancer Treatment Related Side Effects
Total number of cancer treatment related side effects
12 weeks
Patient Rated Pain Score
The Short Form-36 survey was used to measure pain. A high score defines a more favorable health state. Each item is scored on a 0 to 100 range, with the lowest and highest possible scores being 0 and 100, respectively.
12 weeks, measured at the start of their exercise program during their initial assessment and at the 12-week follow-up re-assessment.
Cancer TreatmentTtolerance
Measured by the Eastern Cooperative Oncology Group (ECOG) performance status score. Scale is from 0 to 5, with 0 being high functioning and no restriction and 5 being dead.
12 weeks - ECOG performance status measurements were recorded at baseline and at the 12-week follow up appointment.
Quality of Life Measure: Utilizing McGill Quality of Life Survey and FACT-B Questionnaire
McGill Quality of Life Survey: Physical Wellbeing (questions 1-4) - minimum score is 0, maximum score is 40. A higher score would be good and lower score would be bad. Social Wellbeing (questions 12, 14-16) - minimum score is 0, maximum score is 40. A higher score would be good and lower score would be bad. Emotional Wellbeing(questions 5-7, 13) - minimum score is 0 and maximum score is 40. A higher score would be bad and a lower score would be good Functional wellbeing (questions 8-11) - minimum score is 0, maximum score is 40. A higher score would be good and lower score would be bad. FACT-BREAST Survey: Minimum score is 0 and maximum is 148; 0 is not at all and 4 is very much, "good" or "bad" varies depending on the question; overall a higher score is good and a lower score is bad
Baseline was at the time of enrollment and follow up was after 12-weeks.
Secondary Outcomes (2)
Adherence Rate
12 weeks
Percentage of Participants Who Completed the Study (Attrition Rate)
12 weeks
Study Arms (2)
Exercise Group
EXPERIMENTALPatients will complete a 60-minute exercise session once per week for 12 weeks. The exercise sessions will be individualized to the patient's needs and fitness level by a trainer. A patient will work with the same trainer throughout the study, who will plan the patient's individualized exercise regimen, and who will provide one-on-one supervision for the duration of each 60-minute session. Each 60-minute session will include cardiovascular, strength, and flexibility training. The intensity level for the aerobic exercise ranges from 30-45% of the individual's predicted VO2max, controlled by heart monitors and lasting 30 min. Strength training will involve a full body workout, with emphasis on all major muscle groups and employing machines, free weights, and resistance tubing. Patients will complete 3 sets of 10 repetitions for each strength exercise. Flexibility training will involve static stretching of all major muscle groups for 15-20 seconds at the completion of each workout.
Control Group
ACTIVE COMPARATORThe control group will receive the current standard of care, which includes a resource guide with various options available to the cancer survivor. Within this guide are tips for healthy eating and pictures of standard exercises to improve fitness.
Interventions
The study intervention is a supervised, individualized exercise oncology program described in previous literature2,3,12 and provided by Maple Tree Cancer Alliance, a non-profit organization providing exercise training to individuals with cancer (https://www.mapletreecanceralliance.org/). This organization was founded in 2011 and currently operates in 9 hospitals serving Ohio and Pennsylvania, offering free exercise programs and nutritional guidance to approximately 500 patients annually to help relieve side effects related to cancer treatment.
Resource guide with various options available to cancer survivor. Within this guide are tips for healthy eating and pictures of standard exercises to improve fitness.
Eligibility Criteria
You may qualify if:
- Female; determined from electronic medical record
- Initial stage 0, 1 or 2 breast cancer diagnosis within the past 12 weeks determined from electronic medical record
- Age 30-80; determined from electronic medical record
- Physician clearance to participate in exercise
You may not qualify if:
- Participation in supervised physical exercise within 6 months prior to study enrollment
- Currently pregnant or planning to become pregnant
- Non-English speaking
- Unable to make own medical decisions and/or to follow verbal instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karen Wonderslead
Study Sites (1)
Maple Tree Cancer Alliance
Dayton, Ohio, 45404, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
None to the study itself. Public funding and lack of resources have been identified as a significant barrier to national exercise oncology programs. Other known barriers include lack of general knowledge about the need to stay physically active during and after cancer therapy, qualified personnel, and available programs.
Results Point of Contact
- Title
- Dr. Karen Wonders
- Organization
- Maple Tree Cancer Alliance
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Wonders, PhD, FACSM
Maple Tree Cancer Alliance
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Executive Director, Maple Tree Cancer Alliance
Study Record Dates
First Submitted
September 25, 2019
First Posted
September 27, 2019
Study Start
August 23, 2019
Primary Completion
October 28, 2021
Study Completion
October 28, 2021
Last Updated
June 7, 2024
Results First Posted
June 7, 2024
Record last verified: 2024-06